Variability in CT Referral Data Completeness: Insights from the EU-JUST-CT Project
Author Block: C. Singer1, M. Saban2, L. Bergovoy-Yellin1, B. Brkljačić3, A. Karoussou-Schreiner4, J. Sosna5; 1Ramat Gan/IL, 2Tel Aviv/IL, 3Zagreb/HR, 4Luxembourg/LU, 5Jerusalem/IL
Purpose: To evaluate the quality and completeness of CT referrals using audited data from the EU-JUST-CT project across seven European countries: Belgium, Denmark, Estonia, Finland, Greece, Hungary, and Slovenia (n=6,734 referrals).
Methods or Background: Each referral was evaluated using seven binary indicators: Clinical data sufficient; Examination specified; Referrer specialty; Prior exams; Patient status (in-/outpatient); Patient gender and age. We computed a Completeness Score (sum of all seven indicators) and a Critical Score based on four essential items (clinical data, exam type, gender, and age). We examined the distribution of both scores by country and calculated the proportion of fully complete referrals (Completeness Score = 7) and fully critical-complete referrals (Critical Score = 4).
Results or Findings: The median Completeness Score was 7 in Denmark; 6 in Belgium, Greece, Hungary, and Slovenia; 5 in Estonia; and 4 in Finland. Denmark had the highest mean Completeness Score (6.6), while Finland had the lowest (4.3). The proportion of fully complete referrals ranged from 60.6% (Denmark) to 0.3% (Finland). For the Critical Score, all countries had a median of 4, but inter-country variation in the proportion of referrals with full critical data was observed: (67-98%). The mean Critical Score was highest for Belgium (3.98) and lowest for Slovenia (3.64).
Conclusion: Incomplete information on CT referrals was prevalent, with differences observed between countries. The results presented raise the need for unified protocols and standards, possibly anchored in the national legislation, which dictates what minimal information is required in a CT referral in order to be approved.
Limitations: Our dataset, while large and geographically diverse within Europe, may not generalize to other regions with different healthcare structures, referral styles, or disease prevalence. Additionally, this study did not assess the clinical consequences of incomplete referrals.
Funding for this study: No
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: local research ethics committees or IRBs at each of the 125 participating imaging facilities across the seven countries. At each site, the IRB either approved the study or waived the requirement for informed consent due to the retrospective nature and de-identification of the data.